BUSINESS

• Takeda Drops Diabetic Nephropathy Drug amid Change in R&D Strategy
  May 11, 2016

• Takeda Enjoys Higher Revenues and Profits as Entyvio Sales Triple
  May 11, 2016

• Meiji Seika Pharma Jettisons BPH Treatment
  May 11, 2016

• AZ Set to Double Japan Sales by 2020 on Cancer Meds, No Patent Cliff in Sight: Local Pres. Baertschi
  May 11, 2016

• Taiho Establishes Venture Capital Unit in US to Invest in Field of Oncology
  May 11, 2016

• Daiichi Sankyo Enters License Agreement with UK Company for Cell Therapy
  May 11, 2016

• Aspen Japan Files Requests for Reimbursement Listing of Paxil, Valtrex AGs
  May 10, 2016

• Takeda Gets US$38 Million Grant from Gates Foundation for Polio Vaccine Development
  May 10, 2016

• Thorsten Poehl Takes Helm of Boehringer Japan
  May 10, 2016

• D. Western Therapeutics Acquires Exclusive License to Corneal Endothelial Therapeutics from Doshisha Univ.
  May 10, 2016

• Transfer of Vaccine, Blood Biz under Negotiation, All Directors to Exit in June: Kaketsuken
  May 9, 2016

• Ex-Ranbaxy Shareholders Ordered to Pay 56 Billion Yen to Daiichi Sankyo
  May 9, 2016

• Shingo Iwamoto to Lead Aspen Japan
  May 9, 2016

• Halaven Approved for Advanced Liposarcoma in Europe: Eisai
  May 9, 2016

• Brintellix Renamed Trintellix to Curb Name Confusion in US
  May 9, 2016

• Ono Ups FY2015 Earnings Forecast on Brisk Opdivo Sales
  May 9, 2016

• Sales Rep Survey - Part 2: Drug Makers Exploring Viable Roles amid Govt’s Community-Based Care Initiative
  May 6, 2016

• Sales Rep Survey - Part 1: Number of Reps at Foreign Drug Makers Declines Sharply; Down by 330 at GSK
  May 2, 2016

• 53 Drug Makers Hire 200 Less New Grads in FY2016, Japan Firms See Hefty Drop: Jiho Tally
  April 28, 2016

• Kenji Sukeno to Become New Fujifilm Holdings President
  April 28, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 461
• 462
• 463
• 464
• 465
• 466
• 467
• 468
• 469
• …
• Next ›
• 最終 »